Takeda J, Hashimoto K, Koufuji K, Kodama I, Aoyagi K, Kakegawa T
Department of Surgery, Kurume University School of Medicine, Japan.
Kurume Med J. 1992;39(3):141-5. doi: 10.2739/kurumemedj.39.141.
From 1976 to 1989, a total of 1303 patients with gastric cancers underwent gastrectomies in the First Department of Surgery, Kurume University Hospital. Of these, 358 (27.5%) were total gastrectomies, 84 (6.4%) were proximal gastrectomies and 825 (63.1%) were distal gastrectomies. The 5-year survival rate was 44.8% after the total gastrectomies, 38.9% after the proximal and 72.4% after the distal gastrectomies. The 5-year survival rate was 86.2% with the absolute curative resection, 36.3% with the relative curative resection, 29.3% with the relative non-curative resection and 9.4% with the absolute non-curative resection. Macroscopically, the 5-year survival rate was 95.1% for type 0 (early cancers), 61.3% for Borrmann type 1, 58.8% for Borrmann type 2, 37.5% for Borrmann type 3 and 16.5% for Borrmann type 4. According to the pathological cancer stage, the 5-year survival rate was 94.8% for stage I, 79.3% for stage II, 49.2% for stage III and only 11.3% for stage IV.
1976年至1989年，久留米大学医院第一外科共有1303例胃癌患者接受了胃切除术。其中，全胃切除术358例（27.5%），近端胃切除术84例（6.4%），远端胃切除术825例（63.1%）。全胃切除术后5年生存率为44.8%，近端胃切除术后为38.9%，远端胃切除术后为72.4%。绝对根治性切除术后5年生存率为86.2%，相对根治性切除术后为36.3%，相对非根治性切除术后为29.3%，绝对非根治性切除术后为9.4%。从宏观上看，0型（早期癌症）5年生存率为95.1%，Borrmann 1型为61.3%，Borrmann 2型为58.8%，Borrmann 3型为37.5%，Borrmann 4型为16.5%。根据病理癌症分期，I期5年生存率为94.8%，II期为79.3%，III期为49.2%，IV期仅为11.3%。
